NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) — Free Cash Flow Generation Index
NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) has a Free Cash Flow Generation Index of 1.00x as of December 2022. Free cash flow of $29.08 Million represents 1% of operating cash flow ($29.19 Million). See NAMS current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
NewAmsterdam Pharma Company N.V. Ordinary Shares Free Cash Flow Generation Index (2022–2022)
Historical FCF Generation Index trend for NewAmsterdam Pharma Company N.V. Ordinary Shares across 1 annual periods. Explore NewAmsterdam Pharma Company N.V. Ordinar cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for NewAmsterdam Pharma Company N.V. Ordinary Shares (2022–2022)
Year-by-year Free Cash Flow Generation Index for NewAmsterdam Pharma Company N.V. Ordinary Shares. For the full company profile including market capitalisation, see NAMS company net worth.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.98x | $10.44 Million | $10.66 Million | $221.00K | — |